AG
CMPX icon

Algert Global’s Compass Therapeutics CMPX Stock Holding History

Algert Global’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$195K Buy
+36,780
New +$212K ﹤0.01% 1082
2025
Q1 		– Sell
-22,588
Closed -$33K – 1199
2024
Q4 		$33K Hold
22,588
– – ﹤0.01% 1148
2024
Q3 		$42K Buy
22,588
+6,008
+36% +$7.49K ﹤0.01% 1144
2024
Q2 		$17K Hold
16,580
– – ﹤0.01% 1479
2024
Q1 		$33K Buy
+16,580
New +$28.7K ﹤0.01% 1043
2023
Q4 		– Sell
-33,963
Closed -$67K – 1147
2023
Q3 		$67K Sell
33,963
-54,870
-62% -$136K ﹤0.01% 1054
2023
Q2 		$282K Buy
+88,833
New +$279K 0.01% 923

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM